Do you really know your meds? new study tests GATTEX safety smarts
NCT ID NCT05561647
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This study uses a survey to check how well patients and doctors understand the risks and required monitoring for GATTEX, a medicine for Short Bowel Syndrome. About 600 people (adults who have taken GATTEX recently and their healthcare providers) will answer true/false questions online, by phone, or on paper. No study medicine is given—the goal is simply to measure knowledge and improve safe use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Pharmaceuticals, U.S.A., Inc.
RECRUITINGCambridge, Massachusetts, 02142, United States
Conditions
Explore the condition pages connected to this study.